<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular diseases</z:e> are frequent complications of <z:e sem="disease" ids="C1261469" disease_type="Disease or Syndrome" abbrv="ESRD">end-stage kidney disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study was to prove the arrhythmogenic effect of dialysis using signal averaged ECG </plain></SENT>
<SENT sid="2" pm="."><plain>The ECG changes and laboratory parameters (<z:chebi fb="199" ids="26708">sodium</z:chebi>, <z:chebi fb="120" ids="26216">potassium</z:chebi>, <z:chebi fb="20" ids="16199">urea</z:chebi> and <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels) were detected during hemodialysis treatment in 26 patients suffering from <z:e sem="disease" ids="C1261469" disease_type="Disease or Syndrome" abbrv="ESRD">end-stage kidney disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The tests and the ECG were performed four times, before (0 </plain></SENT>
<SENT sid="4" pm="."><plain>minute), during (at 15 and 90 min), and eventually after dialysis (at 240 min) </plain></SENT>
<SENT sid="5" pm="."><plain>The duration of the QRS complex, high-frequency low-amplitude signals (HFLA), and root-mean-square voltage of the terminal 40 ms of the filtered QRS (RMS) were determined </plain></SENT>
<SENT sid="6" pm="."><plain>We considered test results to be positive when two of the three tested parameters were outside the <z:mpath ids='MPATH_458'>normal</z:mpath> range: QRS &gt; 120 ms, RMS &lt; 20 uV, HFLA &gt; 39 ms </plain></SENT>
<SENT sid="7" pm="."><plain>Signal averaged ECG was positive in two cases (8%) before and after the dialysis </plain></SENT>
<SENT sid="8" pm="."><plain>The duration of the QRS-complex increased significantly during the dialysis (predialysis: 109 +/- 7.6 ms, postdialysis: 116 +/- 8.0 ms, p &lt; 0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>Serum <z:chebi fb="20" ids="16199">urea</z:chebi> nitrogen (predialysis: 26.2 +/- 5.4, postdialysis: 11.4 +/- 3.3 mmol/l, p &lt;0.0001) and serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels (predialysis: 931 +/- 212, postdialysis: 434 +/- 120 micromol/I, p &lt; 0.0001) decreased significantly during the treatment </plain></SENT>
<SENT sid="10" pm="."><plain>Significant and continuous decrease in the <z:chebi fb="120" ids="26216">potassium</z:chebi> levels were detected (predialysis: 5.30 +/- 0.72, postdialysis: 3.91 +/- 0.42 mmol/I, p &lt; 0.0001) during the dialysis </plain></SENT>
<SENT sid="11" pm="."><plain>Serum <z:chebi fb="199" ids="26708">sodium</z:chebi> levels (predialysis: 139 +/- 2.7, postdialysis: 141.4 +/- 2.2 mmol/I) had not changed during the dialysis </plain></SENT>
<SENT sid="12" pm="."><plain>A significant negative correlation was found between decreasing <z:chebi fb="120" ids="26216">potassium</z:chebi> levels and increasing QRS duration (r = - 0.48, p = 0.01) </plain></SENT>
<SENT sid="13" pm="."><plain>Our results support our primer assumption that the metabolic changes during dialysis treatment can lead to considerable risk of <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
</text></document>